st clement's house, 27 clement's lane, london, EC4N 7AE
Website
-
breast and melanoma specialists limitedEstimated Valuation
£174.9k
Pomanda estimates the enterprise value of BREAST AND MELANOMA SPECIALISTS LIMITED at £174.9k based on a Turnover of £470.3k and 0.37x industry multiple (adjusted for size and gross margin).
breast and melanoma specialists limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of BREAST AND MELANOMA SPECIALISTS LIMITED at £0 based on an EBITDA of £-16.6k and a 2.65x industry multiple (adjusted for size and gross margin).
breast and melanoma specialists limitedEstimated Valuation
£3.8m
Pomanda estimates the enterprise value of BREAST AND MELANOMA SPECIALISTS LIMITED at £3.8m based on Net Assets of £1.9m and 2.01x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Breast And Melanoma Specialists LimitedOverview
Breast And Melanoma Specialists Limited is a live company located in london, EC4N 7AE with a Companies House number of 08097924. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in June 2012, it's largest shareholder is
caroline kissin
with a 50% stake. Breast And Melanoma Specialists Limited is a established,
micro sized company, Pomanda has estimated its turnover at
£470.3k with
low
growth in recent years.
Breast And Melanoma Specialists Limited Health Check
Pomanda's financial health check has awarded Breast And Melanoma Specialists Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating3out of 5
3 Strong
1 Regular
6 Weak
Size
annual sales of £470.3k, make it larger than the average company (£387.2k)
£470.3k - Breast And Melanoma Specialists Limited
£387.2k - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (5.5%)
3% - Breast And Melanoma Specialists Limited
5.5% - Industry AVG
Production
with a gross margin of 32%, this company has a higher cost of product (55.4%)
32% - Breast And Melanoma Specialists Limited
55.4% - Industry AVG
Profitability
an operating margin of -3.5% make it less profitable than the average company (14.3%)
-3.5% - Breast And Melanoma Specialists Limited
14.3% - Industry AVG
Employees
with 4 employees, this is below the industry average (9)
4 - Breast And Melanoma Specialists Limited
9 - Industry AVG
Pay Structure
on an average salary of £30.4k, the company has an equivalent pay structure (£30.4k)
£30.4k - Breast And Melanoma Specialists Limited
£30.4k - Industry AVG
Efficiency
resulting in sales per employee of £117.6k, this is more efficient (£74.6k)
£117.6k - Breast And Melanoma Specialists Limited
£74.6k - Industry AVG
Debtor Days
it gets paid by customers after 119 days, this is later than average (35 days)
119 days - Breast And Melanoma Specialists Limited
35 days - Industry AVG
Creditor Days
its suppliers are paid after 1 days, this is quicker than average (38 days)
1 days - Breast And Melanoma Specialists Limited
38 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Breast And Melanoma Specialists Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Breast And Melanoma Specialists Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 0.4%, this is a lower level of debt than the average (31.4%)
0.4% - Breast And Melanoma Specialists Limited
31.4% - Industry AVG
BREAST AND MELANOMA SPECIALISTS LIMITED financials
EXPORT
Breast And Melanoma Specialists Limited's latest turnover from June 2023 is estimated at £470.3 thousand and the company has net assets of £1.9 million. According to their latest financial statements, we estimate that Breast And Melanoma Specialists Limited has 4 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Jun 2017
Jun 2016
Jun 2015
Jun 2014
Jun 2013
Turnover
470,326
542,206
353,892
434,888
3,175,170
2,972,196
3,219,056
902,123
2,136,337
1,604,172
1,156,011
Other Income Or Grants
Cost Of Sales
319,980
342,422
237,287
270,855
1,875,073
1,722,106
1,764,979
468,786
1,133,617
837,339
501,435
Gross Profit
150,346
199,784
116,605
164,034
1,300,096
1,250,090
1,454,077
433,337
1,002,720
766,833
654,575
Admin Expenses
166,991
188,106
116,238
112,819
1,202,894
1,084,383
1,128,114
132,132
581,132
236,540
173,187
Operating Profit
-16,645
11,678
367
51,215
97,202
165,707
325,963
301,205
421,588
530,293
481,388
Interest Payable
Interest Receivable
560
1,985
2,340
2,143
668
Pre-Tax Profit
-16,645
11,678
367
51,215
97,202
165,707
326,523
303,190
423,928
532,437
482,056
Tax
-2,219
-70
-9,731
-18,468
-31,484
-62,039
-60,638
-84,785
-111,812
-110,873
Profit After Tax
-16,645
9,459
297
41,484
78,734
134,223
264,484
242,552
339,142
420,625
371,183
Dividends Paid
Retained Profit
-16,645
9,459
297
41,484
78,734
134,223
264,484
242,552
339,142
420,625
371,183
Employee Costs
121,625
135,594
26,781
75,396
160,108
155,336
141,836
198,402
473,955
389,189
263,018
Number Of Employees
4
5
1
3
6
6
6
7
16
13
9
EBITDA*
-16,645
11,678
367
51,215
97,202
165,707
325,963
301,271
421,676
530,410
481,388
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Jun 2017
Jun 2016
Jun 2015
Jun 2014
Jun 2013
Tangible Assets
1,737,280
1,720,807
1,712,752
1,703,493
20,194
26,962
147
197
263
351
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
1,737,280
1,720,807
1,712,752
1,703,493
20,194
26,962
147
197
263
351
Stock & work in progress
Trade Debtors
153,798
202,031
197,539
211,197
1,862,324
1,780,303
1,701,086
182,607
375,868
319,631
211,968
Group Debtors
Misc Debtors
999
978
1,698
1,848
Cash
448,276
345,673
590,246
267,048
misc current assets
809,509
500,952
total current assets
154,797
203,009
199,237
213,045
1,862,324
1,780,303
1,701,086
1,440,392
1,222,493
909,877
479,016
total assets
1,892,077
1,923,816
1,911,989
1,916,538
1,882,518
1,807,265
1,701,233
1,440,589
1,222,756
910,228
479,016
Bank overdraft
Bank loan
Trade Creditors
1,582
16,268
13,900
18,696
28,995
31,556
63,247
66,087
90,806
117,420
106,833
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
total current liabilities
1,582
16,268
13,900
18,696
28,995
31,556
63,247
66,087
90,806
117,420
106,833
loans
hp & lease commitments
Accruals and Deferred Income
4,957
5,365
5,365
5,415
2,580
3,500
other liabilities
provisions
total long term liabilities
4,957
5,365
5,365
5,415
2,580
3,500
total liabilities
6,539
21,633
19,265
24,111
31,575
35,056
63,247
66,087
90,806
117,420
106,833
net assets
1,885,538
1,902,183
1,892,724
1,892,427
1,850,943
1,772,209
1,637,986
1,374,502
1,131,950
792,808
372,183
total shareholders funds
1,885,538
1,902,183
1,892,724
1,892,427
1,850,943
1,772,209
1,637,986
1,374,502
1,131,950
792,808
372,183
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Jun 2017
Jun 2016
Jun 2015
Jun 2014
Jun 2013
Operating Activities
Operating Profit
-16,645
11,678
367
51,215
97,202
165,707
325,963
301,205
421,588
530,293
481,388
Depreciation
66
88
117
Amortisation
Tax
-2,219
-70
-9,731
-18,468
-31,484
-62,039
-60,638
-84,785
-111,812
-110,873
Stock
Debtors
-48,212
3,772
-13,808
-1,649,279
82,021
79,217
1,518,479
-193,261
56,237
107,663
211,968
Creditors
-14,686
2,368
-4,796
-10,299
-2,561
-31,691
-2,840
-24,719
-26,614
10,587
106,833
Accruals and Deferred Income
-408
-50
2,835
-920
3,500
Deferred Taxes & Provisions
Cash flow from operations
16,473
8,055
9,259
1,683,299
-6,768
26,815
-1,257,395
409,175
254,040
321,522
265,380
Investing Activities
capital expenditure
-16,473
-8,055
-9,259
-1,683,299
6,768
-26,815
50
-468
Change in Investments
cash flow from investments
-16,473
-8,055
-9,259
-1,683,299
6,768
-26,815
50
-468
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-1,000
1,000
interest
560
1,985
2,340
2,143
668
cash flow from financing
-440
1,985
2,340
2,143
1,668
cash and cash equivalents
cash
-448,276
102,603
-244,573
323,198
267,048
overdraft
change in cash
-448,276
102,603
-244,573
323,198
267,048
breast and melanoma specialists limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for breast and melanoma specialists limited. Get real-time insights into breast and melanoma specialists limited's credit score, group structure and payment trends.
Breast And Melanoma Specialists Limited Competitor Analysis
Perform a competitor analysis for breast and melanoma specialists limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in EC4N area or any other competitors across 12 key performance metrics.
breast and melanoma specialists limited Ownership
BREAST AND MELANOMA SPECIALISTS LIMITED group structure
Breast And Melanoma Specialists Limited has no subsidiary companies.
Ultimate parent company
BREAST AND MELANOMA SPECIALISTS LIMITED
08097924
BREAST AND MELANOMA SPECIALISTS LIMITED Shareholders
The largest shareholders in Breast And Melanoma Specialists Limited include Caroline Kissin and Mark Kissin.
caroline kissin
50%
mark kissin
50%
breast and melanoma specialists limited directors
Breast And Melanoma Specialists Limited currently has 2 directors.
The longest serving directors include
Dr Caroline Kissin (Jun 2012) and
Mr Mark Kissin (Jun 2012).
breast and melanoma specialists limited company details
company number
08097924
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
June 2012
age
13
incorporated
UK
ultimate parent company
None
accounts
Micro-Entity Accounts
last accounts submitted
June 2023
previous names
N/A
accountant
-
auditor
-
address
st clement's house, 27 clement's lane, london, EC4N 7AE
Bank
-
Legal Advisor
-
breast and melanoma specialists limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to breast and melanoma specialists limited.
breast and melanoma specialists limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BREAST AND MELANOMA SPECIALISTS LIMITED. This can take several minutes, an email will notify you when this has completed.
breast and melanoma specialists limitedCompanies House Filings - See Documents
